Zkusit zdarma
Gilead Sciences, Inc.

Gilead Sciences, Inc.

GILD
Cena:
$ 134.36
+3.86 (2.96%)
Valuace
18
Růst
10
Zdraví
80
Souhrn Finanční data Pro investory Předpovědi Zprávy Dividendy Zisky Návštěvnost webu Akcionáři
Souhrn
Finanční data
Pro investory
Předpovědi
Zprávy
Dividendy
Zisky
Návštěvnost webu
Akcionáři

Zprávy

Zahraniční články
Tiskové zprávy
Dokumenty ke stáhnutí
US FDA approves Gilead's drug for deadly liver infection

US FDA approves Gilead's drug for deadly liver infection

14:06 22-05-2026

The U.S. Food and ​Drug Administration said on ‌Friday it approved Gilead Sciences' drug for a r...

FDA Grants Accelerated Approval to Gilead's Hepcludex® (bulevirtide-gmod), the First and Only Approved Treatment for Chronic Hepatitis Delta Virus (HDV)

FDA Grants Accelerated Approval to Gilead's Hepcludex® (bulevirtide-gmod), the First and Only Approved Treatment for Chronic Hepatitis Delta Virus (HDV)

14:00 22-05-2026

Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the U.S. Food and Drug Administration (FDA...

New ASCO and EHA 2026 Data Demonstrate Gilead and Kite's Momentum Across Antibody-Drug Conjugates and Cell Therapy in Oncology

New ASCO and EHA 2026 Data Demonstrate Gilead and Kite's Momentum Across Antibody-Drug Conjugates and Cell Therapy in Oncology

17:00 21-05-2026

FOSTER CITY, Calif. & SANTA MONICA, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) to...

Why Gilead Sciences Is Now A Hold (Rating Upgrade)

Why Gilead Sciences Is Now A Hold (Rating Upgrade)

9:46 21-05-2026

Gilead Sciences, Inc. once again demonstrated strong performance of Trodelvy, Livdelzi, and Yeztugo....

Gilead Sciences Completes Acquisition of Tubulis Further Strengthening Oncology Portfolio

Gilead Sciences Completes Acquisition of Tubulis Further Strengthening Oncology Portfolio

9:30 21-05-2026

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced the succe...

Gilead Sciences and World Health Organization Expand Collaboration to Help Eliminate Visceral Leishmaniasis, a Fatal Parasitic Disease

Gilead Sciences and World Health Organization Expand Collaboration to Help Eliminate Visceral Leishmaniasis, a Fatal Parasitic Disease

4:00 21-05-2026

Gilead Sciences, Inc. (Nasdaq: GILD) today announced a renewed five-year collaboration with the Worl...

Gilead Sciences and World Health Organization Expand Collaboration to Help Eliminate Visceral Leishmaniasis, a Fatal Parasitic Disease

Gilead Sciences and World Health Organization Expand Collaboration to Help Eliminate Visceral Leishmaniasis, a Fatal Parasitic Disease

3:30 21-05-2026

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced a renewed...

Gilead Sciences, Inc. (GILD) Is a Trending Stock: Facts to Know Before Betting on It

Gilead Sciences, Inc. (GILD) Is a Trending Stock: Facts to Know Before Betting on It

10:01 20-05-2026

Gilead (GILD) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wi...

Gilead Sciences, Inc. (GILD) Presents at RBC Capital Markets Global Healthcare Conference 2026 Transcript

Gilead Sciences, Inc. (GILD) Presents at RBC Capital Markets Global Healthcare Conference 2026 Transcript

13:20 19-05-2026

Gilead Sciences, Inc. (GILD) Presents at RBC Capital Markets Global Healthcare Conference 2026 Trans...

Gilead Sciences Leans on HIV Growth as Deals Build Oncology, Inflammation Pipeline

Gilead Sciences Leans on HIV Growth as Deals Build Oncology, Inflammation Pipeline

9:03 17-05-2026

Gilead Sciences NASDAQ: GILD Chief Commercial Officer and Head of Corporate Affairs Johanna Mercier ...

Gilead Prices $3 Billion of Senior Unsecured Notes

Gilead Prices $3 Billion of Senior Unsecured Notes

21:21 14-05-2026

FOSTER CITY, Calif.--(BUSINESS WIRE)-- #GILD--Gilead Sciences, Inc. (Nasdaq: GILD), a biopharmaceuti...

Is It Worth Investing in Gilead (GILD) Based on Wall Street's Bullish Views?

Is It Worth Investing in Gilead (GILD) Based on Wall Street's Bullish Views?

10:30 13-05-2026

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or H...

Gilead's Transition Into A Long-Duration Biotech Platform

Gilead's Transition Into A Long-Duration Biotech Platform

9:15 13-05-2026

Gilead Sciences is executing a successful transition from a mature antiviral company to a diversifie...

Gilead Sciences, Inc. (GILD) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Gilead Sciences, Inc. (GILD) Presents at Bank of America Global Healthcare Conference 2026 Transcript

20:00 12-05-2026

Gilead Sciences, Inc. (GILD) Presents at Bank of America Global Healthcare Conference 2026 Transcrip...

GILD Beats Q1 Earnings and Sales Estimates, Lowers '26 EPS View

GILD Beats Q1 Earnings and Sales Estimates, Lowers '26 EPS View

12:26 08-05-2026

GILD beats Q1 estimates as HIV and Trodelvy sales rise, but shares slip after the company cuts its 2...

Gilead Sciences, Inc. (GILD) Q1 2026 Earnings Call Transcript

Gilead Sciences, Inc. (GILD) Q1 2026 Earnings Call Transcript

1:01 08-05-2026

Gilead Sciences, Inc. (GILD) Q1 2026 Earnings Call Transcript...

Gilead (GILD) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

Gilead (GILD) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

19:01 07-05-2026

Although the revenue and EPS for Gilead (GILD) give a sense of how its business performed in the qua...

Gilead Sciences (GILD) Tops Q1 Earnings and Revenue Estimates

Gilead Sciences (GILD) Tops Q1 Earnings and Revenue Estimates

18:16 07-05-2026

Gilead Sciences (GILD) came out with quarterly earnings of $2.03 per share, beating the Zacks Consen...

Gilead Sciences Expects Loss This Year on Acquired R&D Expenses

Gilead Sciences Expects Loss This Year on Acquired R&D Expenses

16:39 07-05-2026

The biopharmaceutical company said it expects a 2026 adjusted loss of between $1.05 and 65 cents a s...

Gilead raises 2026 sales forecast, cuts profit outlook due to acquisitions

Gilead raises 2026 sales forecast, cuts profit outlook due to acquisitions

16:05 07-05-2026

Gilead Sciences on Thursday posted a higher-than-expected first-quarter profit and raised its outloo...

close

GILEAD SCIENCES ANNOUNCES 3.8 PERCENT INCREASE IN FIRST QUARTER 2026 DIVIDEND

10-02-2026
FOSTER CITY, CALIF.--(BUSINESS WIRE)-- #DIVIDEND--GILEAD SCIENCES, INC. (NASDAQ: GILD) TODAY ANNOUNC...
Více zde

GILEAD SCIENCES ANNOUNCES FOURTH QUARTER AND FULL YEAR 2025 FINANCIAL RESULTS

10-02-2026
FOSTER CITY, CALIF.--(BUSINESS WIRE)-- #EARNINGS--GILEAD SCIENCES, INC. (NASDAQ: GILD) ANNOUNCED TOD...
Více zde

FDA APPROVES LABEL UPDATE FOR KITE'S YESCARTA® FOR RELAPSED/REFRACTORY PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA

06-02-2026
SANTA MONICA, CALIF.--(BUSINESS WIRE)--KITE, A GILEAD COMPANY (NASDAQ: GILD), TODAY ANNOUNCED THE U....
Více zde

GILEAD SCIENCES TO RELEASE FOURTH QUARTER & FULL YEAR 2025 FINANCIAL RESULTS ON TUESDAY, FEBRUARY 10, 2026

27-01-2026
FOSTER CITY, CALIF.--(BUSINESS WIRE)-- #EARNINGS--GILEAD SCIENCES, INC. (NASDAQ: GILD) ANNOUNCED TOD...
Více zde

NEW ENGLAND JOURNAL OF MEDICINE PUBLISHES PHASE 3 ASCENT-04/KEYNOTE-D19 RESULTS SUPPORTING TRODELVY® PLUS KEYTRUDA® AS A POTENTIAL NEW STANDARD OF CARE IN FIRST-LINE PD-L1+ METASTATIC TRIPLE-NEGATIVE BREAST CANCER

21-01-2026
FOSTER CITY, CALIF.--(BUSINESS WIRE)--GILEAD SCIENCES, INC. (NASDAQ: GILD) TODAY ANNOUNCED THE NEW E...
Více zde

ONCONANO MEDICINE ANNOUNCES RESEARCH COLLABORATION WITH GILEAD TO APPLY ON-BOARD™ DELIVERY TECHNOLOGY TO GILEAD'S DRUG CANDIDATE

06-01-2026
DALLAS--(BUSINESS WIRE)--ONCONANO MEDICINE, INC. (“ONCONANO”) TODAY ANNOUNCED A RESEARCH COLLABO...
Více zde

GILEAD SCIENCES TO PRESENT AT UPCOMING INVESTOR CONFERENCE

22-12-2025
FOSTER CITY, CALIF.--(BUSINESS WIRE)-- #GILD--GILEAD SCIENCES, INC. (NASDAQ: GILD) ANNOUNCED TODAY T...
Více zde

GILEAD SCIENCES EXERCISES OPTION TO LICENSE ASSEMBLY BIOSCIENCES' HELICASE-PRIMASE INHIBITOR PROGRAMS FOR RECURRENT GENITAL HERPES

22-12-2025
FOSTER CITY, CALIF. & SOUTH SAN FRANCISCO, CALIF.--(BUSINESS WIRE)--GILEAD SCIENCES, INC. (NASDAQ: G...
Více zde

GILEAD AND U.S. GOVERNMENT ENTER AGREEMENT TO LOWER COSTS OF MEDICINES FOR AMERICANS

19-12-2025
FOSTER CITY, CALIF.--(BUSINESS WIRE)--GILEAD SCIENCES, INC. (NASDAQ: GILD) TODAY ANNOUNCED AN AGREEM...
Více zde

GILEAD SCIENCES APPOINTS KEELEY WETTAN AS EXECUTIVE VICE PRESIDENT, GENERAL COUNSEL, LEGAL & COMPLIANCE

18-12-2025
FOSTER CITY, CALIF.--(BUSINESS WIRE)--GILEAD SCIENCES, INC. (NASDAQ: GILD) ANNOUNCED TODAY THAT KEEL...
Více zde

GILEAD'S INVESTIGATIONAL SINGLE-TABLET REGIMEN OF BICTEGRAVIR AND LENACAPAVIR FOR HIV TREATMENT MEETS PRIMARY ENDPOINT IN PHASE 3 ARTISTRY-2 TRIAL

15-12-2025
FOSTER CITY, CALIF.--(BUSINESS WIRE)--GILEAD SCIENCES, INC. (NASDAQ: GILD) TODAY ANNOUNCED POSITIVE ...
Více zde

GILEAD FOUNDATION AWARDS OVER $3 MILLION TO SUPPORT PEOPLE LIVING WITH METASTATIC BREAST CANCER

09-12-2025
FOSTER CITY, CALIF.--(BUSINESS WIRE)--GILEAD FOUNDATION AWARDS $3M IN GRANTS TO CLOSE GAPS IN EDUCAT...
Více zde

YESCARTA® DELIVERS CONSISTENT SAFETY, EFFICACY, AND QUALITY OF LIFE BENEFITS ACROSS BROAD RANGE OF RELAPSED/REFRACTORY LARGE B-CELL LYMPHOMA PATIENTS IN NEW ANALYSIS AT ASH 2025

07-12-2025
SANTA MONICA, CALIF.--(BUSINESS WIRE)--KITE, A GILEAD COMPANY (NASDAQ: GILD), PRESENTED A NEW ANALYS...
Více zde

KITE ANNOUNCES NEW DATA FOR PIVOTAL IMMAGINE-1 STUDY AT ASH 2025, HIGHLIGHTING ANITO-CEL'S OPPORTUNITY IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA

06-12-2025
SANTA MONICA, CALIF.--(BUSINESS WIRE)--KITE, A GILEAD COMPANY (NASDAQ: GILD), AND ITS PARTNER ARCELL...
Více zde

GILEAD FOUNDATION COMMITS OVER $3 MILLION TO ADDRESS FOOD INSECURITY

24-11-2025
FOSTER CITY, CALIF.--(BUSINESS WIRE)--GILEAD FOUNDATION TODAY ANNOUNCED THAT IT HAS COMMITTED OVER $...
Více zde

ASPEN NEUROSCIENCE ANNOUNCES $115 MILLION SERIES C FINANCING TO ACCELERATE PERSONALIZED CELL THERAPY PROGRAMS

20-11-2025
SAN DIEGO , NOV. 20, 2025 /PRNEWSWIRE/ -- ASPEN NEUROSCIENCE, INC., A CLINICAL-STAGE BIOTECHNOLOGY ...
Více zde

GILEAD JOINS PARTNERS FOR DELIVERY OF FIRST SHIPMENTS OF BREAKTHROUGH TWICE-YEARLY LENACAPAVIR FOR HIV PREVENTION TO SUB-SAHARAN AFRICA

18-11-2025
FOSTER CITY, CALIF. & MBABANE, ESWATINI--(BUSINESS WIRE)--GILEAD SCIENCES, INC. (NASDAQ: GILD) TODAY...
Více zde

GILEAD'S INVESTIGATIONAL SINGLE-TABLET REGIMEN OF BICTEGRAVIR AND LENACAPAVIR FOR HIV-1 TREATMENT MEETS PRIMARY ENDPOINT IN PHASE 3 ARTISTRY-1 TRIAL

13-11-2025
FOSTER CITY, CALIF.--(BUSINESS WIRE)--GILEAD SCIENCES, INC. (NASDAQ: GILD) TODAY ANNOUNCED POSITIVE ...
Více zde

AHF'S MOBILE BILLBOARD CALLS OUT GILEAD'S GREED AT PHARMA SUMMIT

10-11-2025
LOS ANGELES--(BUSINESS WIRE)--AS THE PHARMACEUTICAL INDUSTRY GATHERS FOR THE GLOBAL PHARMA & BIOTECH...
Více zde

GILEAD PROVIDES UPDATE ON PHASE 3 ASCENT-07 STUDY

07-11-2025
FOSTER CITY, CALIF.--(BUSINESS WIRE)--GILEAD SCIENCES, INC. (NASDAQ: GILD) TODAY ANNOUNCED THE PHASE...
Více zde

GILEAD'S LIVDELZI® DEMONSTRATES SUSTAINED EFFICACY IN PRIMARY BILIARY CHOLANGITIS (PBC), OFFERING ALKALINE PHOSPHATASE (ALP) REDUCTION, ITCH RELIEF AND POTENTIAL TO SLOW DISEASE PROGRESSION

07-11-2025
FOSTER CITY, CALIF.--(BUSINESS WIRE)--GILEAD SCIENCES, INC. (NASDAQ: GILD) TODAY ANNOUNCED NEW LONG-...
Více zde

GILEAD SCIENCES TO PRESENT AT UPCOMING INVESTOR CONFERENCES

04-11-2025
FOSTER CITY, CALIF.--(BUSINESS WIRE)-- #GILD--GILEAD SCIENCES, INC. (NASDAQ: GILD) ANNOUNCED TODAY T...
Více zde

GILEAD AND KITE SHOWCASE CONTINUED PROGRESS IN TRANSFORMING BLOOD CANCER CARE WITH NEW CELL THERAPY DATA AT ASH 2025

03-11-2025
FOSTER CITY, CALIF.--(BUSINESS WIRE)--GILEAD SCIENCES, INC. (NASDAQ: GILD) AND KITE, A GILEAD COMPAN...
Více zde

GILEAD SCIENCES WINS PRESTIGIOUS 2025 PRIX GALIEN USA AWARD FOR BEST PHARMACEUTICAL PRODUCT WITH YEZTUGO® (LENACAPAVIR)

31-10-2025
FOSTER CITY, CALIF.--(BUSINESS WIRE)--GILEAD SCIENCES, INC. (NASDAQ: GILD) TODAY ANNOUNCED IT HAS BE...
Více zde

GILEAD SCIENCES ANNOUNCES THIRD QUARTER 2025 FINANCIAL RESULTS

30-10-2025
FOSTER CITY, CALIF.--(BUSINESS WIRE)-- #EARNINGS--GILEAD SCIENCES, INC. (NASDAQ: GILD) ANNOUNCED TOD...
Více zde

VICTORY! AHF, 100 ORGANIZATIONS KILL GILEAD'S GREEDY DRUG PRICE HIKES

29-10-2025
WASHINGTON--(BUSINESS WIRE)--VICTORY! AHF, 100 ORGANIZATIONS KILL GILEAD'S GREEDY DRUG PRICE HIKES....
Více zde

GILEAD TO SHOWCASE INTERIM LONG-TERM EFFICACY DATA FOR LIVDELZI® (SELADELPAR) IN PRIMARY BILIARY CHOLANGITIS (PBC) AND INVESTIGATIONAL BULEVIRTIDE IN CHRONIC HEPATITIS DELTA

23-10-2025
FOSTER CITY, CALIF.--(BUSINESS WIRE)--GILEAD SCIENCES, INC. (NASDAQ: GILD) WILL PRESENT NEW RESEARCH...
Více zde

AHF: 80 ORGANIZATIONS DENOUNCE GILEAD ON PRICE HIKES GUTTING ADAP

21-10-2025
WASHINGTON--(BUSINESS WIRE)--AHF: 80 ORGANIZATIONS DENOUNCE GILEAD ON PRICE HIKES GUTTING ADAP....
Více zde

GILEAD TO SPOTLIGHT NEW VIROLOGY DATA ACROSS HIV, VIRAL HEPATITIS AND RESPIRATORY DISEASES AT IDWEEK 2025

19-10-2025
FOSTER CITY, CALIF.--(BUSINESS WIRE)--GILEAD SCIENCES, INC. (NASDAQ: GILD) WILL PRESENT NEW FINDINGS...
Více zde

TRODELVY® REDUCES RISK OF DISEASE PROGRESSION OR DEATH BY 38% VERSUS CHEMOTHERAPY AS FIRST-LINE THERAPY IN PATIENTS WITH METASTATIC TRIPLE-NEGATIVE BREAST CANCER IN ASCENT-03 STUDY

19-10-2025
FOSTER CITY, CALIF.--(BUSINESS WIRE)--GILEAD SCIENCES, INC. (NASDAQ: GILD) TODAY SHARED POSITIVE DAT...
Více zde

close

Datum Typ Otevřít EDGAR Stáhnout dokument
2026-02-10 00:00:008-KStáhnout
2025-11-19 00:00:008-KStáhnout
2025-11-07 00:00:0010-QStáhnout
2025-10-30 00:00:008-KStáhnout
2025-10-06 01:00:008-KStáhnout
2025-10-06 00:00:008-KStáhnout
2025-08-14 01:00:008-KStáhnout
2025-08-14 00:00:008-KStáhnout
2025-08-07 01:00:008-KStáhnout
2025-08-07 01:00:0010-QStáhnout
2025-08-07 00:00:008-KStáhnout
2025-08-07 00:00:0010-QStáhnout
2025-08-04 01:00:008-KStáhnout
2025-08-04 00:00:008-KStáhnout
2025-05-08 01:00:008-KStáhnout
2025-05-08 00:00:008-KStáhnout
2025-05-07 01:00:0010-QStáhnout
2025-05-07 00:00:0010-QStáhnout
2025-04-24 01:00:008-KStáhnout
2025-04-24 00:00:008-KStáhnout
2025-03-12 00:00:008-KStáhnout
2025-03-11 23:00:008-KStáhnout
2025-02-28 00:00:0010-KStáhnout
2025-02-27 23:00:0010-KStáhnout
2025-02-11 00:00:008-KStáhnout
2025-02-10 23:00:008-KStáhnout
2024-11-20 00:00:008-KStáhnout
2024-11-19 23:00:008-KStáhnout
2024-11-12 00:00:0010-QStáhnout
2024-11-11 23:00:0010-QStáhnout
2024-11-06 00:00:008-KStáhnout
2024-11-05 23:00:008-KStáhnout
2024-08-08 01:00:008-KStáhnout
2024-08-08 01:00:0010-QStáhnout
2024-08-08 00:00:008-KStáhnout
2024-08-08 00:00:0010-QStáhnout
2024-07-17 01:00:008-KStáhnout
2024-07-17 00:00:008-KStáhnout
2024-05-09 01:00:008-KStáhnout
2024-05-09 00:00:008-KStáhnout
2024-05-08 01:00:0010-QStáhnout
2024-05-08 00:00:0010-QStáhnout
2024-04-25 01:00:008-KStáhnout
2024-04-25 00:00:008-KStáhnout
2024-03-22 00:00:008-KStáhnout
2024-03-21 23:00:008-KStáhnout
2024-03-14 00:00:008-KStáhnout
2024-03-13 23:00:008-KStáhnout
2024-02-23 00:00:0010-KStáhnout
2024-02-22 23:00:0010-KStáhnout
2024-02-12 00:00:008-KStáhnout
2024-02-11 23:00:008-KStáhnout
2024-02-06 00:00:008-KStáhnout
2024-02-05 23:00:008-KStáhnout
2024-02-02 00:00:008-KStáhnout
2024-02-01 23:00:008-KStáhnout
2023-11-07 00:00:008-KStáhnout
2023-11-07 00:00:0010-QStáhnout
2023-11-06 23:00:008-KStáhnout
2023-11-06 23:00:0010-QStáhnout
2023-09-14 01:00:008-KStáhnout
2023-09-14 00:00:008-KStáhnout
2023-08-16 01:00:008-KStáhnout
2023-08-16 00:00:008-KStáhnout
2023-08-04 01:00:0010-QStáhnout
2023-08-04 00:00:0010-QStáhnout
2023-08-03 01:00:008-KStáhnout
2023-08-03 00:00:008-KStáhnout
2023-05-05 01:00:008-KStáhnout
2023-05-05 00:00:008-KStáhnout
2023-05-03 01:00:0010-QStáhnout
2023-05-03 00:00:0010-QStáhnout
2023-04-27 01:00:008-KStáhnout
2023-04-27 00:00:008-KStáhnout
2023-02-22 00:00:0010-KStáhnout
2023-02-21 23:00:0010-KStáhnout
2023-02-06 00:00:008-KStáhnout
2023-02-05 23:00:008-KStáhnout
2023-02-02 00:00:008-KStáhnout
2023-02-01 23:00:008-KStáhnout
2022-11-02 00:00:0010-QStáhnout
2022-11-01 23:00:0010-QStáhnout
2022-10-27 01:00:008-KStáhnout
2022-10-27 00:00:008-KStáhnout
2022-09-12 01:00:008-KStáhnout
2022-09-12 00:00:008-KStáhnout
2022-08-08 01:00:0010-QStáhnout
2022-08-08 00:00:0010-QStáhnout
2022-08-02 01:00:008-KStáhnout
2022-08-02 00:00:008-KStáhnout
2022-07-28 01:00:008-KStáhnout
2022-07-28 00:00:008-KStáhnout
2022-05-31 01:00:008-KStáhnout
2022-05-31 00:00:008-KStáhnout
2022-05-05 01:00:008-KStáhnout
2022-05-05 00:00:008-KStáhnout
2022-05-04 01:00:0010-QStáhnout
2022-05-04 00:00:0010-QStáhnout
2022-04-28 01:00:008-KStáhnout
2022-04-28 00:00:008-KStáhnout
2022-03-07 00:00:008-KStáhnout
2022-03-06 23:00:008-KStáhnout
2022-02-23 00:00:0010-KStáhnout
2022-02-22 23:00:0010-KStáhnout
2022-02-01 00:00:008-KStáhnout
2022-01-31 23:00:008-KStáhnout
2022-01-06 00:00:008-KStáhnout
2022-01-05 23:00:008-KStáhnout
2021-11-03 00:00:0010-QStáhnout
2021-11-02 23:00:0010-QStáhnout
2021-10-28 01:00:008-KStáhnout
2021-10-28 00:00:008-KStáhnout
2021-08-05 01:00:0010-QStáhnout
2021-08-05 00:00:0010-QStáhnout
2021-07-29 01:00:008-KStáhnout
2021-07-29 00:00:008-KStáhnout
2021-05-14 01:00:008-KStáhnout
2021-05-14 00:00:008-KStáhnout
2021-05-06 01:00:0010-QStáhnout
2021-05-06 00:00:0010-QStáhnout
2021-04-29 01:00:008-KStáhnout
2021-04-29 00:00:008-KStáhnout
2021-02-25 00:00:0010-KStáhnout
2021-02-24 23:00:0010-KStáhnout
2021-02-04 00:00:008-KStáhnout
2021-02-03 23:00:008-KStáhnout
2021-01-11 00:00:008-KStáhnout
2021-01-10 23:00:008-KStáhnout
2020-12-08 00:00:008-KStáhnout
2020-12-07 23:00:008-KStáhnout
2020-11-04 00:00:0010-QStáhnout
2020-11-03 23:00:0010-QStáhnout
2020-10-28 00:00:008-KStáhnout
2020-10-27 23:00:008-KStáhnout
2020-10-23 01:00:008-KStáhnout
2020-10-23 00:00:008-KStáhnout
2020-10-22 01:00:008-KStáhnout
2020-10-22 00:00:008-KStáhnout
2020-09-30 01:00:008-KStáhnout
2020-09-30 00:00:008-KStáhnout
2020-09-29 01:00:008-KStáhnout
2020-09-29 00:00:008-KStáhnout
2020-09-14 01:00:008-KStáhnout
2020-09-14 00:00:008-KStáhnout
2020-08-06 01:00:0010-QStáhnout
2020-08-06 00:00:0010-QStáhnout
2020-07-30 01:00:008-KStáhnout
2020-07-30 00:00:008-KStáhnout
2020-06-16 01:00:008-KStáhnout
2020-06-16 00:00:008-KStáhnout
2020-05-08 01:00:008-KStáhnout
2020-05-08 00:00:008-KStáhnout
2020-05-06 01:00:0010-QStáhnout
2020-05-06 00:00:0010-QStáhnout
2020-04-30 01:00:008-KStáhnout
2020-04-30 00:00:008-KStáhnout
2020-03-02 00:00:008-KStáhnout
2020-03-01 23:00:008-KStáhnout
2020-02-25 00:00:0010-KStáhnout
2020-02-24 23:00:0010-KStáhnout
2020-02-04 00:00:008-KStáhnout
2020-02-03 23:00:008-KStáhnout
2020-01-31 00:00:008-KStáhnout
2020-01-30 23:00:008-KStáhnout
2019-11-05 00:00:0010-QStáhnout
2019-11-04 23:00:0010-QStáhnout
2019-10-24 01:00:008-KStáhnout
2019-10-24 00:00:008-KStáhnout
2019-10-15 01:00:008-KStáhnout
2019-10-15 00:00:008-KStáhnout
2019-08-27 01:00:008-KStáhnout
2019-08-27 00:00:008-KStáhnout
2019-08-06 01:00:0010-QStáhnout
2019-08-06 00:00:0010-QStáhnout
2019-07-30 01:00:008-KStáhnout
2019-07-30 00:00:008-KStáhnout
2019-07-18 01:00:008-KStáhnout
2019-07-18 00:00:008-KStáhnout
2019-07-17 01:00:008-KStáhnout
2019-07-17 00:00:008-KStáhnout
2019-05-29 01:00:008-KStáhnout
2019-05-29 00:00:008-KStáhnout
2019-05-09 01:00:008-KStáhnout
2019-05-09 00:00:008-KStáhnout
2019-05-08 01:00:0010-QStáhnout
2019-05-08 00:00:0010-QStáhnout
2019-05-02 01:00:008-KStáhnout
2019-05-02 00:00:008-KStáhnout
2019-05-01 01:00:008-KStáhnout
2019-05-01 00:00:008-KStáhnout
2019-03-01 00:00:008-KStáhnout
2019-02-28 23:00:008-KStáhnout
2019-02-26 00:00:0010-KStáhnout
2019-02-25 23:00:0010-KStáhnout
2019-02-04 00:00:008-KStáhnout
2019-02-03 23:00:008-KStáhnout
2018-12-10 00:00:008-KStáhnout
2018-12-09 23:00:008-KStáhnout
2018-11-06 00:00:0010-QStáhnout
2018-11-05 23:00:0010-QStáhnout
2018-10-25 01:00:008-KStáhnout
2018-10-25 00:00:008-KStáhnout
2018-09-18 01:00:008-KStáhnout
2018-09-18 00:00:008-KStáhnout
2018-08-07 01:00:008-KStáhnout
2018-08-07 00:00:008-KStáhnout
2018-08-06 01:00:0010-QStáhnout
2018-08-06 00:00:0010-QStáhnout
2018-07-26 01:00:008-KStáhnout
2018-07-26 00:00:008-KStáhnout
2018-07-25 01:00:008-KStáhnout
2018-07-25 00:00:008-KStáhnout
2018-05-11 01:00:008-KStáhnout
2018-05-11 00:00:008-KStáhnout
2018-05-09 01:00:0010-QStáhnout
2018-05-09 00:00:0010-QStáhnout
2018-05-01 01:00:008-KStáhnout
2018-05-01 00:00:008-KStáhnout
2018-02-27 00:00:0010-KStáhnout
2018-02-26 23:00:0010-KStáhnout
2018-02-06 00:00:008-KStáhnout
2018-02-05 23:00:008-KStáhnout
2018-02-05 00:00:008-KStáhnout
2018-02-04 23:00:008-KStáhnout
2017-12-18 00:00:008-KStáhnout
2017-12-17 23:00:008-KStáhnout
2017-11-07 00:00:0010-QStáhnout
2017-11-06 23:00:0010-QStáhnout
2017-10-26 01:00:008-KStáhnout
2017-10-26 00:00:008-KStáhnout
2017-09-28 01:00:008-KStáhnout
2017-09-28 00:00:008-KStáhnout
2017-09-21 01:00:008-KStáhnout
2017-09-21 00:00:008-KStáhnout
2017-09-20 01:00:008-KStáhnout
2017-09-20 00:00:008-KStáhnout
2017-09-13 01:00:008-KStáhnout
2017-09-13 00:00:008-KStáhnout
2017-08-28 01:00:008-KStáhnout
2017-08-28 00:00:008-KStáhnout
2017-08-07 01:00:0010-QStáhnout
2017-08-07 00:00:0010-QStáhnout
2017-07-26 01:00:008-KStáhnout
2017-07-26 00:00:008-KStáhnout
2017-05-12 01:00:008-KStáhnout
2017-05-12 00:00:008-KStáhnout
2017-05-10 01:00:0010-QStáhnout
2017-05-10 00:00:0010-QStáhnout
2017-05-02 01:00:008-KStáhnout
2017-05-02 00:00:008-KStáhnout
2017-02-27 00:00:0010-KStáhnout
2017-02-26 23:00:0010-KStáhnout
2017-02-21 00:00:008-KStáhnout
2017-02-20 23:00:008-KStáhnout
2017-02-08 00:00:008-KStáhnout
2017-02-07 23:00:008-KStáhnout
2017-02-07 00:00:008-KStáhnout
2017-02-06 23:00:008-KStáhnout
2016-11-07 00:00:0010-QStáhnout
2016-11-06 23:00:0010-QStáhnout
2016-11-01 00:00:008-KStáhnout
2016-10-31 23:00:008-KStáhnout
2016-09-20 01:00:008-KStáhnout
2016-09-20 00:00:008-KStáhnout
2016-08-23 01:00:008-KStáhnout
2016-08-23 00:00:008-KStáhnout
2016-08-05 01:00:0010-QStáhnout
2016-08-05 00:00:0010-QStáhnout
2016-07-25 01:00:008-KStáhnout
2016-07-25 00:00:008-KStáhnout
2016-05-25 01:00:008-KStáhnout
2016-05-25 00:00:008-KStáhnout
2016-05-17 01:00:008-KStáhnout
2016-05-17 00:00:008-KStáhnout
2016-05-06 01:00:0010-QStáhnout
2016-05-06 00:00:0010-QStáhnout
2016-04-28 01:00:008-KStáhnout
2016-04-28 00:00:008-KStáhnout
2016-03-11 00:00:008-KStáhnout
2016-03-10 23:00:008-KStáhnout
2016-02-24 00:00:0010-KStáhnout
2016-02-23 23:00:0010-KStáhnout
2016-02-03 00:00:008-KStáhnout
2016-02-02 23:00:008-KStáhnout
2016-02-02 00:00:008-KStáhnout
2016-02-01 23:00:008-KStáhnout
2015-12-23 00:00:008-KStáhnout
2015-12-22 23:00:008-KStáhnout
2015-11-04 00:00:0010-QStáhnout
2015-11-03 23:00:0010-QStáhnout
2015-10-27 00:00:008-KStáhnout
2015-10-26 23:00:008-KStáhnout
2015-09-14 00:00:008-KStáhnout
2015-08-05 00:00:0010-QStáhnout
2015-07-28 00:00:008-KStáhnout
preloader